Rapamycin as an Adjunctive Therapy for NLRC4 Associated Macrophage Activation Syndrome-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Rapamycin as an Adjunctive Therapy for NLRC4 Associated Macrophage Activation Syndrome

Published:2018-09-24 Issue: Volume:9 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Barsalou Julie,Blincoe Annaliesse,Fernandez Isabel,Dal-Soglio Dorothée,Marchitto Lorie,Selleri Silvia,Haddad Elie,Benyoucef Aissa,Touzot Fabien

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference15 articles.

1. Mutation of NLRC4 causes a syndrome of enterocolitis and autoinflammation;Romberg;Nat Genet.,2014

2. Mammalian target of rapamycin inhibition counterbalances the inflammatory status of immune cells in patients with chronic granulomatous disease;Gabrion;J Allergy Clin Immunol.,2017

3. Rapamycin regulates macrophage activation by inhibiting NLRP3 inflammasome-p38 MAPK-NFκB pathways in autophagy- and p62-dependent manners;Ko;Oncotarget,2017

4. Antigen-independent IFN-γ production by human naïve CD4 T cells activated by IL-12 plus IL-18;Munk;PLoS ONE,2011

5. Autophagy controls IL-1beta secretion by targeting pro-IL-1beta for degradation;Harris;J Biol Chem.,2011

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. NLRC4, inflammation and colorectal cancer (Review);International Journal of Oncology;2024-09-04

2. The NLRP3 inflammasome is essential for IL-18 production in a murine model of macrophage activation syndrome;Disease Models & Mechanisms;2024-07-01

3. Targeted treatments for immune dysregulation in inborn errors of immunity;Exploration of Immunology;2024-04-23

4. The NLRP3 inflammasome is essential for IL-18 production in a murine model of macrophage activation syndrome;2024-03-01

5. HLH as an additional warning sign of inborn errors of immunity beyond familial-HLH in children: a systematic review;Frontiers in Immunology;2024-02-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3